Literature DB >> 11444640

Successful external cardioversion of atrial fibrillation in patients referred to an electrophysiologist for internal cardioversion.

R J Verdino1, J J Teuteberg, M C Burke, D E Kopp, C T Johnson, A C Lin, M Alberts, J G Kall, D J Wilber.   

Abstract

BACKGROUND: Internal cardioversion of atrial fibrillation with direct current energy has become an increasingly employed technique for patients who fail external cardioversion. HYPOTHESIS: The purpose of this study was to determine whether internal cardioversion could be avoided by careful attention to cardioversion technique in a group of patients referred specifically for internal cardioversion after failed external cardioversion by community cardiologists.
METHODS: We performed external cardioversion utilizing two operators applying significant pressure to the thorax with up to 360 J prior to the planned internal cardioversion in 20 patients referred for internal cardioversion after failed attempts at external cardioversion.
RESULTS: Sixteen patients (80%) were successfully cardioverted and avoided the risk, inconvenience, and cost of internal cardioversion.
CONCLUSION: External cardioversion with significant anterior paddle pressure by two operators can decrease the need for internal cardioversion in a significant portion of patients referred to electrophysiologists for internal cardioversion and should be considered prior to an invasive procedure.

Entities:  

Mesh:

Year:  2001        PMID: 11444640      PMCID: PMC6654876          DOI: 10.1002/clc.4960240716

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  12 in total

1.  Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation.

Authors:  H Li; A Natale; G Tomassoni; S Beheiry; P Cooper; F Leonelli; A Easley; W Barrington; J Windle
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

2.  Double external direct-current shocks for refractory atrial fibrillation.

Authors:  P Bjerregaard; A El-Shafei; D L Janosik; L Schiller; A Quattromani
Journal:  Am J Cardiol       Date:  1999-03-15       Impact factor: 2.778

3.  Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?

Authors:  E N Prystowsky
Journal:  Am J Cardiol       Date:  2000-08-01       Impact factor: 2.778

4.  Initial energy for elective external cardioversion of persistent atrial fibrillation.

Authors:  J A Joglar; M H Hamdan; K Ramaswamy; J D Zagrodzky; C J Sheehan; L L Nelson; T C Andrews; R L Page
Journal:  Am J Cardiol       Date:  2000-08-01       Impact factor: 2.778

5.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors:  B LOWN; R AMARASINGHAM; J NEUMAN
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

6.  Optimal technique for electrical cardioversion of atrial fibrillation.

Authors:  G A Ewy
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

7.  Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform.

Authors:  R A Winkle; R H Mead; M A Ruder; V Gaudiani; W S Buch; B Pless; M Sweeney; P Schmidt
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

8.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

Authors:  H Oral; J J Souza; G F Michaud; B P Knight; R Goyal; S A Strickberger; F Morady
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

9.  The use of atropine for facilitation of direct current cardioversion from atrial fibrillation--results of a pilot study.

Authors:  A G Sutton; C Khurana; J A Hall; A Davies; M A de Belder
Journal:  Clin Cardiol       Date:  1999-11       Impact factor: 2.882

10.  A randomized comparison of external and internal cardioversion of chronic atrial fibrillation.

Authors:  S Lévy; P Lauribe; E Dolla; W Kou; A Kadish; H Calkins; F Pagannelli; C Moyal; M Bremondy; A Schork
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.